Detail akcie Balchem online

Business Summary: Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, Balchem Corp revenues increased 9% to $1.04B. Net income increased 21% to $154.8M. Revenues reflect Human nutrition & health segment increase of 10% to $659.4M, Animal Nutrition & Health segment increase of 8% to $230.9M, Foreign Countries segment increase of 21% to $277.7M, United States segment increase of 5% to $759.4M.